1. Home
  2. KEQU vs PLYX Comparison

KEQU vs PLYX Comparison

Compare KEQU & PLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

HOLD

Current Price

$34.92

Market Cap

106.6M

Sector

Industrials

ML Signal

HOLD

PLYX

Polaryx Therapeutics Inc. Common Stock

N/A

Current Price

$5.49

Market Cap

114.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KEQU
PLYX
Founded
1906
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
106.6M
114.1M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
KEQU
PLYX
Price
$34.92
$5.49
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
6.2K
1.9M
Earning Date
03-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.09
N/A
Revenue
$138,558,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$16.44
N/A
Revenue Growth
7.72
N/A
52 Week Low
$30.33
$2.20
52 Week High
$60.89
$8.15

Technical Indicators

Market Signals
Indicator
KEQU
PLYX
Relative Strength Index (RSI) 29.36 51.83
Support Level N/A $2.44
Resistance Level $41.38 $7.43
Average True Range (ATR) 1.29 1.09
MACD -0.81 0.26
Stochastic Oscillator 0.00 57.78

Price Performance

Historical Comparison
KEQU
PLYX

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About PLYX Polaryx Therapeutics Inc. Common Stock

Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small molecule drug candidates designed to address core pathological mechanisms common to LSDs.

Share on Social Networks: